DARIFENACIN

Generic: DARIFENACIN

Rising Pharma HoldingsManufacturer
ORALRoute
DARIFENACIN HYDROBROMIDEActive Substance
2016-09-19Original Approval

DARIFENACIN is FDA application ANDA206743, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
185 reports
2
HERPES ZOSTER
136 reports
3
PERIPHERAL SWELLING
135 reports
4
PNEUMONIA VIRAL
117 reports
5
ARTHRALGIA
113 reports
6
SYNOVITIS
107 reports
7
ANAEMIA
102 reports
8
FIBROMYALGIA
100 reports
9
ARTHRITIS
98 reports
10
BLOOD CHOLESTEROL INCREASED
97 reports